 Latest News
CTP Director Co-Authors New Journal Commentary on the Relative Risks of Tobacco Products
On April 16, Nature Medicine published a new commentary co-authored by FDA’s Center for Tobacco Products (CTP) Director Brian King, Ph.D., M.P.H., discussing considerations for healthcare providers around talking to adults about the relative risks of different tobacco products.
In conjunction with this release, CTP launched a new webpage aimed at educating the public about the relative risks of tobacco products. CTP will continue to update the information on this new webpage based on the best available science.
FDA Launches Searchable Tobacco Products Database
On March 28, FDA launched the Searchable Tobacco Products Database, a new user-friendly list of tobacco products—including e-cigarettes—that may be legally marketed in the United States. The database is designed to serve the public—especially retailers—by providing this key information in a single location, with easy-to-use search capabilities. The database, which can be accessed at www.fda.gov/searchtobacco, will be updated on a monthly basis.
On May 6, FDA’s first update was uploaded to the database. Due to timing factors associated with the initial launch, the products included in this update cover a longer time period (January through mid-April 2024) than will typically be included in the future.
FDA Encourages Research to Promote Diversity in the Tobacco Regulatory Science Workforce
On April 1, the National Institutes of Health (NIH) issued a Notice of Information encouraging the submission of research supplements to promote diversity in the tobacco regulatory science workforce. The opportunity is available to Program Directors/Principal Investigators who are conducting tobacco regulatory research as part of the Tobacco Regulatory Science Program (TRSP), an interagency partnership between the NIH and the FDA Center for Tobacco Products (CTP).
FDA Resumes Posting Regulatory Science Policy Memos on Premarket Review Process
On April 2, FDA released several scientific review policy memoranda that provide a snapshot of CTP’s internal thinking on certain aspects of tobacco regulatory science. This action is consistent with commitments made by CTP to post scientific policy memos and reviewer guides, as appropriate, in response to the 2022 Reagan-Udall Foundation’s operational evaluation of the center. These memos reflect FDA’s current thinking and are subject to change based on changes in policy, regulatory framework, or regulatory science.
PMTA Decisions
FDA continues to make decisions on PMTAs, including the following:
-
April 15, 2024: Marketing Denial Orders for Shenzhen Yibo Technology Co. Ltd. (MNGO Disposable Stick)
Population Assessment of Tobacco and Health (PATH) Study Updates
- The FDA’s Center for Tobacco Products (CTP) and NIH’s National Institute on Drug Abuse (NIDA) are sponsoring a Population Assessment of Tobacco and Health (PATH) Study Data User Workshop to further the understanding and use of PATH Study data files. CTP and NIDA are offering an in-person option in July and a virtual-only option in August. The free course is designed for academic faculty and research professionals, as well as graduate students interested in tobacco regulatory science, tobacco prevention or translation research. Both workshop sessions (in-person or virtual-only) offer the same content. To attend, please apply by May 31. Enrollment is limited and admission is not guaranteed.
- FDA’s Center for Tobacco Products (CTP) and NIH’s National Institute on Drug Abuse (NIDA) released the Wave 7 Restricted-Use File (RUF) from the Population Assessment of Tobacco and Health (PATH) Study. These Wave 7 files contain data collected between January 2022 and April 2023, including questionnaire data, tobacco Universal Product Code (UPC) data, and state identifier data. Researchers may apply for access to the Restricted-Use Files.
- In addition, the PATH Study Biomarker Restricted-Use Files (BRUF) have been updated to include additional assays from Wave 4 and Wave 5. The PATH Study Restricted-Use Files (RUF) have been updated to include Wave 6 Ever/Never reference data for all participants. The Restricted-Use and Public-Use Master Linkage Files have each been updated to reflect the new RUF files and the current availability of biospecimens in the Biospecimen Access Program.
 |
More About CTP Research
Current Funding Opportunities
- Notice of Information Encouraging Submission of Research Supplements to Promote Diversity in Tobacco Regulatory Science through PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - NOT-OD-24-074)
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - RFA-OD-22-023 or RFA-OD-22-024)
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - RFA-OD-22-025 or RFA-OD-22-026)
- Tobacco Regulatory Science (R01 - RFA-OD-23-017)
- FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science (FDABAA-24-00123)
- FDA Support for Conferences and Scientific Meetings (R13 - PAR-23-072)
Recent Publications by CTP Researchers
|
This newsletter serves as a digest of the latest announcements and stories out of CTP. It is a complement to our CTP Connect newsletter and CTP News e-blasts.
|
